|Bid||102.01 x 1400|
|Ask||102.55 x 800|
|Day's range||101.35 - 102.97|
|52-week range||86.02 - 119.65|
|Beta (5Y monthly)||0.33|
|PE ratio (TTM)||83.37|
|Forward dividend & yield||2.92 (2.84%)|
|Ex-dividend date||14 Sept 2023|
|1y target est||N/A|
The FDA grants priority review to Merck's (MRK) FDA filing for sotatercept to treat adults with pulmonary arterial hypertension. A final decision is expected before March 2023-end.
Alphabet, Exxon Mobil, Merck, Abbott Laboratories and NextEra Energy are part of the Zacks top Analyst Blog.
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Exxon Mobil Corp. (XOM) and Merck & Co., Inc. (MRK).